Home General Biotechnology Drug Patent Expirations in July 2012

Drug Patent Expirations in July 2012

Drug Patent Expirations for July 2012

TradenameApplicantGeneric NamePatent NumberPatent Expiration
JEVTANA KITSanofi Aventis Uscabazitaxel5698582Jul 3, 2012
ISTODAXCelgeneromidepsin4977138Jul 6, 2012
NEUROLITELantheus Medcltechnetium tc-99m bicisate kit5431900Jul 11, 2012
CERVIDILControlled Therapdinoprostone5269321Jul 14, 2012
RESCULASucampo Pharmsunoprostone isopropyl5221763Jul 15, 2012
MULTAQSanofi Aventis Usdronedarone hydrochloride5223510Jul 26, 2012
EVISTALillyraloxifene hydrochloride6906086Jul 28, 2012
EVISTALillyraloxifene hydrochlorideRE38968Jul 28, 2012
EVISTALillyraloxifene hydrochloride5393763Jul 28, 2012
EVISTALillyraloxifene hydrochlorideRE39049Jul 28, 2012
EVISTALillyraloxifene hydrochloride5457117Jul 28, 2012
LAMICTAL CDGlaxosmithklinelamotrigine5698226*PEDJul 29, 2012
ETHYOLMedimmuneamifostine5424471Jul 31, 2012
ETHYOLMedimmuneamifostine5591731Jul 31, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison. Contact Us with any questions.